Treatment | Unit | IC50
|
---|
| | NCI-H358a
| MCF-7b
| HeLac
| Hep-2d
| MRC5e
|
---|
Aah venom | μg/mL | 369.20 ± 1.33 | 458 ± 1.39 | >500 | >500 | >500 |
Cisplatin | μM | 11.2 ± 1.3 | 5.2 ± 1.6 | 6.31 ± 2.59 | 20 ± 1.8 | 9.3 ± 0.6 |
- Cells were treated with Aah venom or positive control (cisplatin) at varying concentrations for 24 h and cell viability was determined by MTT assay. IC50 is the concentration of compound that inhibits cell growth by 50 % and values represent mean ± SD of three independent experiments
-
aNCI-H358: human lung adenocarcinoma cell line; bMCF7: human breast cancer cell line; cHeLa: human cervix adenocarcinoma; dHep-2: human laryngeal carcinoma cell line; eMRC5: normal human lung fibroblast